Literature DB >> 3162458

Long term follow-up and HLA association in patients with postpartum hypothyroidism.

J Tachi1, N Amino, H Tamaki, M Aozasa, Y Iwatani, K Miyai.   

Abstract

The long term clinical outcome of postpartum hypothyroidism was investigated by follow-up studies of 44 patients (59 postpartum episodes; mean age of mothers at delivery, 28.2 yr) 5 or more yr later (mean interval after delivery, 8.7 yr; range, 5-16 yr). Forty-nine episodes (83%) in 34 women were followed by recovery within 1 yr postpartum, and those women remained euthyroid thereafter (group A); 10 women [10 episodes (17%)] developed permanent hypothyroidism during the follow-up period (group B). Five women in group B recovered during the first year, but became hypothyroid again later, the other 5 women in Group B remained persistently hypothyroid. HLA typing revealed significantly higher frequencies of HLA-DR3, -DRW8, -DRW9, -A26, -BW46, and -BW67, and significantly lower frequencies of HLA-DR2, -BW52, -BW62, and -CW7 in women with postpartum hypothyroidism than in normal women. Of 9 women with postpartum hypothyroidism who had HLA-DRW9 and/or -B51 associated with antithyroglobulin-antibody titers of 2(3) X 10 or higher, 6 developed permanent hypothyroidism. We conclude that long term follow-up is essential for women of postpartum hypothyroidism because of the risk of permanent hypothyroidism. The results suggest that some immunogenetic factors may be related to the etiology of postpartum hypothyroidism and that women with HLA-DRW9 and/or -B51 and higher titers of antithyroglobulin antibody are likely to develop permanent hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162458     DOI: 10.1210/jcem-66-3-480

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Postpartum thyroid dysfunction in an Italian population residing in an area of mild iodine deficiency.

Authors:  E Roti; L Bianconi; E Gardini; R Minelli; M L De Franco; A Bacchi Modena; D Bresciani; P Villa; T M Neri; M Savi
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

2.  Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum.

Authors:  Alex Stagnaro-Green; Marcos Abalovich; Erik Alexander; Fereidoun Azizi; Jorge Mestman; Roberto Negro; Angelita Nixon; Elizabeth N Pearce; Offie P Soldin; Scott Sullivan; Wilmar Wiersinga
Journal:  Thyroid       Date:  2011-07-25       Impact factor: 6.568

Review 3.  Delineating the autoimmune mechanisms in Graves' disease.

Authors:  Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

4.  Increased postpartum thyroxine replacement in Hashimoto's thyroiditis.

Authors:  Juan C Galofré; Richard S Haber; Adele A Mitchell; Rachel Pessah; Terry F Davies
Journal:  Thyroid       Date:  2010-08       Impact factor: 6.568

5.  Age as a predictor of recurrent hypothyroidism in patients with post-partum thyroid dysfunction.

Authors:  F Azizi
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 6.  Thyroid autoimmunity and female gender.

Authors:  L Chiovato; P Lapi; E Fiore; M Tonacchera; A Pinchera
Journal:  J Endocrinol Invest       Date:  1993-05       Impact factor: 4.256

7.  Post-partum thyroiditis in a mediterranean population: a prospective study of a large cohort of thyroid antibody positive women at the time of delivery.

Authors:  M Kita; D G Goulis; A Avramides
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

Review 8.  [Thyroid diseases and pregnancy].

Authors:  Stefan Karger; Dagmar Führer-Sakel
Journal:  Med Klin (Munich)       Date:  2009-06-16

9.  Follow up of patients with postpartum thyroiditis: a population-based study.

Authors:  Farzaneh Sarvghadi; Mehdi Hedayati; Yadollah Mehrabi; Fereidoun Azizi
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.